Partnership Brief
For Serial Entrepreneurs and Advisors
You have seen this movie before. They have not.
The founders you advise are making the same commercial mistakes you made in your first company. The difference is you know what they are. Wiremap puts that diagnosis in writing before it costs them 12 months of runway.
For
Advisors and serial founders working with early stage companies
The offer
Co-branded GTM diagnosis for your portfolio companies
Your benefit
Structured tool to surface and address the blind spots you already see
Wiremap · Independent Growth Intelligence · B2B · wiremap.co
amulya@wiremap.co
The problem you already know
What you see in every early stage company
The founder is the last person to see their own blind spot.
You have been in the room enough times to recognise the pattern within the first hour. The ICP is too broad. The outreach targets the wrong person. The motion that worked in one market is being copied into a new one without adaptation. The founder knows something is wrong but cannot name it. You can. The problem is there is rarely a clean, structured way to get that observation out of your head and into a format the founder can act on.
The gap between knowing and fixing
Advisory conversations surface the diagnosis. They rarely produce the documented plan the founder can execute from.
Most advisory relationships work like this: you identify the issue in a conversation, the founder nods and agrees, they leave the meeting with a general sense of what needs to change, and three months later the same issue is still present because it was never translated into a specific action plan with a clear sequence. The conversation was valuable. The output was not durable.
What you typically see
  • A founder who has defined their ideal customer by who has bought from them rather than who converts fastest and stays longest
  • Outreach that talks to users of the product rather than the people who control the budget to buy it
  • A motion that worked in one geography being replicated in a new market without adapting for the different buyer behaviour
  • A sales cycle that is entirely dependent on the founder being in every conversation with no documented process behind it
  • A product with genuine differentiation that is not visible in the positioning because the founder is too close to it to see how it sounds from the outside
What the founder typically hears from you
  • You need to narrow your ICP
  • You are talking to the wrong buyer
  • The US market is not India, change the approach
  • You need to document this before you hire anyone
  • Your differentiation is not coming through in the pitch
The advice is right. The problem is that advice without a structured diagnosis to back it up is easy for a founder to hear, agree with, and then not act on because they do not know where to start.
What Wiremap does
The service
A structured diagnosis that turns your instinct into their action plan.
Wiremap runs a formal GTM diagnostic on the companies you advise. The founder completes a structured intake. A practitioner with 20 years of B2B commercial experience analyses it. The output is a specific written report that names the root cause, explains why it exists, quantifies what it is costing the business, and gives three prioritised actions in sequence. The conversation you have been having in advisory sessions becomes a durable document the founder can act from.
The Wiremap approach
Not a framework. Not a scorecard. The specific answer to the specific problem limiting this company's growth right now.
Every report starts with a verdict on the cover page, a one or two sentence diagnosis that a founder reads in ten seconds and immediately recognises as true. Then a Founder Brief that covers what we found, why it matters, what it is costing them, and what to do about it. Then the root cause in full. Then the evidence. Then the cost of inaction. Then three actions and a CEO board slide. The structure is designed to be taken directly into a board meeting or investor update.
7
Business days
From intake submission to report delivery. The founder does not need to schedule calls or wait weeks. The process is entirely asynchronous.
3
Actions only
Every report ends with three actions in priority order. Not fifteen recommendations. The constraint forces prioritisation and makes execution immediate.
0
Calls required
The entire process runs through a structured intake form. No calls required from the founder and none from the advisor. The diagnosis is self-contained.
How it works for advisors
The process
Four steps from your recommendation to their report.
You do not need to be involved in the process beyond the initial recommendation. Wiremap handles the intake, the analysis, and the delivery. You receive a summary of the findings so the next advisory conversation can build on what the report identified rather than starting from scratch.
1
You recommend a diagnosis
You identify a founder in your network or advisory portfolio who is at a commercial inflection point, preparing to hire, scale outreach, raise, or enter a new market. You recommend a Wiremap GTM diagnosis. This can be framed as a structured pre-decision diagnostic rather than a critique of what they are currently doing.
Your time: one conversation
2
The founder completes the intake
The founder receives a structured intake form with 35 to 50 questions covering their commercial motion, ideal customer definition, outreach approach, conversion data, and where they believe the constraint is. They complete it at their own pace over 14 days. No calls, no preparation required.
Founder time: 30 to 45 minutes
3
Wiremap delivers the report
The intake is analysed against 20 years of B2B commercial experience and pattern matched against hundreds of similar commercial situations. The report is delivered to the founder within 7 business days. It contains a cover verdict, a founder brief, the root cause in full, the evidence, the cost of inaction, and three prioritised actions.
Delivery: 7 business days from intake submission
4
You receive a summary and the next conversation is better
You receive a one-page summary of the primary finding. The next advisory session can go straight to the action plan rather than re-diagnosing the problem from scratch. The founder arrives at that session with a documented diagnosis they have already read and processed, which changes the quality of the conversation entirely.
Advisor time: one page to read
The most valuable thing about having a diagnosis in writing is that the founder stops debating whether the problem exists and starts debating how to solve it. That shift saves three to six months of advisory time.
Wiremap, pattern observed across GTM diagnostic engagements
Products and partnership
What is available
Three diagnostics matched to three commercial situations.
Each product is matched to a specific commercial decision the founder is facing. The right diagnosis depends on where the company is and what decision is imminent.
GTM Clarity Assessment
$499 · 7 days
For founders at pre-revenue to $300K annual recurring revenue who are building the commercial motion from scratch or who have been at it for 6 to 12 months without clear traction. Diagnoses the root cause limiting early commercial progress.
Ideal when: founder has been pitching for 3 to 12 months with inconsistent results
Ideal when: preparing to hire a first sales person and wants to document the motion first
Ideal when: about to raise pre-seed or seed and needs a defensible commercial narrative
GTM Risk Assessment
$999 · 7 days
For founders with a motion running, $200K to $2M annual recurring revenue, who are about to make a significant commercial decision. Diagnoses whether the current motion is ready to be scaled or whether scaling it will amplify the wrong direction.
Ideal when: considering hiring a VP Sales or Head of GTM
Ideal when: planning to significantly increase outbound volume or budget
Ideal when: entering a new geography or market segment
Revenue Due Diligence
$2,499 · 10 days
For funded founders preparing for a Series A or B raise. Produces an investor-grade analysis of the commercial motion including repeatability, scalability, and the specific constraints that would concern a lead investor.
Ideal when: 60 to 90 days from initiating fundraise conversations
Ideal when: investor has flagged questions about GTM scalability in previous conversations
Ideal when: the founder wants to walk into investor meetings with a clean commercial narrative
Partnership arrangement
Refer a company. Receive a finder's commission and a summary of every report delivered.
For advisors who recommend Wiremap diagnostics to founders in their network, we offer a 15% referral commission on every completed engagement. You also receive a one-page summary of the primary finding from every report, so your next advisory session builds on what the diagnosis uncovered. There is no formalisation required, a conversation to align is all it takes to get started.
Amulya S Kashyap
amulya@wiremap.co
wiremap.co
Confidential · amulya@wiremap.co · wiremap.co
Data and learning notice: Anonymised and aggregated findings from this assessment may be used to train and improve Wiremap's diagnostic models, pattern library, and report generation capabilities. No identifying information about your company, team, or founders will be disclosed. By submitting an intake form, you consent to this use of anonymised data. Full privacy policy at wiremap.co/privacy.